Literature DB >> 16549816

The molecular perspective: cisplatin.

David S Goodsell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16549816     DOI： 10.1634/theoncologist.11-3-316

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  7 in total

1.  Cervical dissecting extravasation of oxaliplatin: A case report.

Authors:  Jorge Hernando; Judit Riera-Arnau; Maria Roca; Alejandro Garcia; Jaume Capdevila
Journal:  Mol Clin Oncol       Date:  2022-01-12

2.  Prognostic Factors for the Therapeutic Performance of Cisplatin in Head and Neck Malignancies.

Authors:  Frederic Jungbauer; Lena Huber; Sonja Ludwig; Nicole Rotter; Beatrice Walter; Lena Zaubitzer; Anne Lammert
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

3.  Platinum Drug Sensitivity Polymorphisms in Stage III Non-small Cell Lung Cancer With Invasion of Mediastinal Lymph Nodes.

Authors:  Anca Nastase; Audrey Lupo; Victoria Laszlo; Diane Damotte; Simona Dima; Emelyne Canny; Marco Alifano; Irinel Popescu; Walter Klepetko; Madalina Grigoroiu
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

4.  Identification of BC005512 as a DNA damage responsive murine endogenous retrovirus of GLN family involved in cell growth regulation.

Authors:  Yuanfeng Wu; Xinming Qi; Likun Gong; Guozhen Xing; Min Chen; Lingling Miao; Jun Yao; Takayoshi Suzuki; Chie Furihata; Yang Luan; Jin Ren
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

Review 5.  Exploring estrogenic activity in lung cancer.

Authors:  Bartosz Kazimierz Słowikowski; Margarita Lianeri; Paweł Piotr Jagodziński
Journal:  Mol Biol Rep       Date:  2016-10-25       Impact factor: 2.316

Review 6.  NSAID-Based Coordination Compounds for Biomedical Applications: Recent Advances and Developments.

Authors:  Ariana C F Santos; Luís P G Monteiro; Adriana C C Gomes; Fátima Martel; Teresa M Santos; Bárbara J M Leite Ferreira
Journal:  Int J Mol Sci       Date:  2022-03-05       Impact factor: 5.923

7.  Utilisation of nanoparticle technology in cancer chemoresistance.

Authors:  Duncan Ayers; Alessandro Nasti
Journal:  J Drug Deliv       Date:  2012-11-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.